- Serum IL‑21 levels predict HBeAg decline during rescue therapy in patients with partial response to nucleos(t)ide analogues
Yue Li et al, 2021, Experimental and Therapeutic Medicine CrossRef - Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
Ying Xie et al, 2024, Molecular Cancer CrossRef - Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection
Lixin Xiao et al, 2024, Cytokine CrossRef - Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs
Yutaka Enomoto et al, 2017, Scientific Reports CrossRef - Review of the potential value of serum interleukin levels as prognostic biomarkers of liver failure
Yong Lin et al, 2024, World Journal of Clinical Cases CrossRef - NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Evanthia Tourkochristou et al, 2022, Frontiers in Immunology CrossRef - Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
Ali A. Dawood et al, 2021, Medical Immunology (Russia) CrossRef - Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease
Xudong Liu et al, 2016, Journal of Interferon & Cytokine Research CrossRef - Cytokines and Chemokines in HBV Infection
Shihong Zhong et al, 2021, Frontiers in Molecular Biosciences CrossRef - Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory response
Hanchen Xu et al, 2017, Oncotarget CrossRef - Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure
Lili Zhang et al, 2022, Mediators of Inflammation CrossRef